Harmony Biosciences Inc. (HRMY)
38.08
-0.17 (-0.44%)
At close: Jan 28, 2025, 2:54 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | 128.85M | 181.47M | 34.60M | -36.94M | -151.98M | -39.90M |
| Depreciation & Amortization | 24.36M | 23.39M | 18.84M | 10.24M | 3.21M | 184.00K |
| Stock-Based Compensation | 31.70M | 26.17M | 15.66M | 4.69M | 9.91M | 1.08M |
| Other Working Capital | 46.55M | 12.87M | 15.46M | 12.83M | 8.74M | 446.00K |
| Other Non-Cash Items | 12.85M | 3.49M | 2.68M | 4.91M | 55.13M | 2.06M |
| Deferred Income Tax | -13.42M | -85.94M | 26.15M | 25.75M | n/a | n/a |
| Change in Working Capital | 35.03M | -4.11M | 631.00K | -11.63M | 8.29M | -164.00K |
| Operating Cash Flow | 219.39M | 144.47M | 98.56M | -2.98M | -75.44M | -38.80M |
| Capital Expenditures | -312.00K | -40.17M | -100.30M | -2.00M | -127.15M | -1.34M |
| Acquisitions | -36.97M | 141.83M | -100.00M | -2.00M | -52.00M | n/a |
| Purchase of Investments | -127.47M | -110.73M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 118.31M | 9.07M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -141.83M | 100.00M | 2.00M | 52.00M | n/a |
| Investing Cash Flow | -46.44M | -141.83M | -100.30M | -2.00M | -127.15M | -1.34M |
| Debt Repayment | -1.25M | -2.00M | -500.00K | 79.42M | 100.00M | n/a |
| Common Stock Repurchased | -100.00M | n/a | n/a | -167.00K | -1.13M | -3.20M |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -4.30M | 8.84M | -22.08M | -17.71M | 93.77M | 24.82M |
| Financial Cash Flow | -105.55M | 6.84M | 7.42M | 209.16M | 143.77M | 21.61M |
| Net Cash Flow | 67.40M | 9.47M | 5.68M | 204.17M | -58.82M | -18.53M |
| Free Cash Flow | 219.07M | 104.29M | -1.74M | -4.99M | -202.59M | -40.14M |